Clinical Trials Logo

Traumatic Brain Injury clinical trials

View clinical trials related to Traumatic Brain Injury.

Filter by:

NCT ID: NCT00676182 Completed - Clinical trials for Traumatic Brain Injury

Telerehabilitation for OIF/OEF Returnees With Combat-Related Traumatic Brain Injury

Start date: July 2008
Phase: N/A
Study type: Observational

The scientific objective of this program is to meet the rehabilitation needs of combat wounded Veterans with mild to moderate Traumatic Brain Injury (TBI) via telerehabilitation and determine the effect of this modality of care on patients' physical health and outcomes including function and community participation. The investigators will also evaluate the benefits and limitations of rehabilitation using telehealth from the Veteran and caregiver perspectives and evaluate the impact of rehabilitation via telehealth on Veterans Administration (VA) healthcare facility use.

NCT ID: NCT00653640 Completed - Clinical trials for Traumatic Brain Injury

Physical Work Capacity After Traumatic Brain Injury

Start date: May 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether body weight supported treadmill training is more effective than traditional physical therapy at restoring gait in persons recovering from traumatic brain injury.

NCT ID: NCT00631436 Recruiting - Clinical trials for Traumatic Brain Injury

The Effects of Explosive Blast as Compared to Post-Traumatic Stress Disorder on Brain Function and Structure

Start date: April 2008
Phase: N/A
Study type: Observational

Brain injury from explosive blast is a prominent feature of contemporary combat. Although protective armor and effective acute medical intervention allows soldiers to survive blast events, a growing number of veterans will have disability stemming from blast-related neural damage. Soldiers also return from combat with psychological disabilities caused by traumatic war events. The clinical presentation of individuals with blast-related neural damage and post-traumatic psychopathology are markedly similar and thus a clear description of the direct consequences of explosive blast is complicated by the emotional and cognitive sequelae of psychological trauma. We will use sophisticated measures of neural function and structure to characterize brain injury from explosive blasts in a sample of Operation Iraqi Freedom (OIF) National Guard soldiers who returned from deployment in the fall of 2007. Survey data gathered near the end of deployment indicated that over 50% of the brigade had been exposed to direct physical effects of explosive blasts. To fully characterize the effects of blast on the brain and differentiate them from post-traumatic stress disorder, we will contrast groups of soldiers exposed to blast and with groups experiencing post-traumatic stress disorder. This investigation will improve the characterization of blast-related traumatic brain injury, describe the essential features of the condition in terms of neural function and structure to inform diagnosis, and characterize mechanisms of recovery after blast-related neural injury to allow the creation of interventions that return soldiers to maximum levels of functioning.

NCT ID: NCT00627250 Completed - Clinical trials for Traumatic Brain Injury

Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic Irritability

Start date: March 2003
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if amantadine hydrochloride given 100 mg in the morning and at noon is safe and effective in the treatment of mood and behavior changes (i.e. irritability) after sustaining traumatic brain injury.

NCT ID: NCT00627237 Completed - Clinical trials for Traumatic Brain Injury

Improving Executive Functioning After Traumatic Brain Injury (TBI): A Trial of the "Short Term Executive Plus" Program

STEP
Start date: January 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the efficacy of an intensive short term cognitive rehabilitation program aimed towards improving executive functioning in individuals with traumatic brain injury (TBI).

NCT ID: NCT00623506 Completed - Clinical trials for Traumatic Brain Injury

Adjunctive Pregnenolone in Veterans With Mild TBI

Start date: January 2008
Phase: N/A
Study type: Interventional

Mild traumatic brain injury (TBI) is common among veterans who have served in OEF/OIF (Operation Enduring Freedom in Afghanistan/Operation Iraqi Freedom) and other theatres. Delayed symptoms may occur following TBI, including cognitive symptoms (impaired attention, processing speed, executive functioning), as well as behavioral symptoms such as anxiety, depression, and irritability (Fann et al. 2004; Holsinger et al. 2002). Neuroactive steroids have neuroprotective effects in rodent models of TBI (Djebaili et al. 2005; Djebaili et al. 2004; He et al. 2004; Pettus et al. 2005; Roof et al. 1997) and the neuroactive steroid pregnenolone and its sulfated derivative also markedly enhance learning and memory in rats (Akwa et al. 2001; Flood et al. 1992; Flood et al. 1995; Vallee et al. 1997; Vallee et al. 2003). In humans, reductions in pregnenolone (George et al. 1994) and its GABAergic metabolite allopregnanolone (Uzunova et al. 1998) have been associated with depressive symptoms. Pharmacological intervention with the neuroactive steroid pregnenolone could therefore result in a multi-targeted treatment approach, potentially improving cognitive deficits as well as anxiety and depression symptoms following TBI.

NCT ID: NCT00622570 Terminated - Clinical trials for Traumatic Brain Injury

Comparison of Effectiveness of Pentobarbital and Thiopental in Patients With Refractory Intracranial Hypertension

Start date: May 2002
Phase: Phase 3
Study type: Interventional

Objective: to assess the effectiveness of pentobarbital and thiopental to control raised intracranial pressure (ICP), refractory to first level measures, in patients with severe traumatic brain injury. Material and methods: prospective, randomized open study to compare the effectiveness between two treatments: pentobarbital and thiopental. The patients will be selected from those admitted to the Intensive Care Unit with a severe traumatic brain injury (postresuscitation Glasgow Coma Scale equal or less than 8 points) and raised ICP (ICP>20 mmHg) refractory to first level measures according to the Brain Trauma Foundation guidelines. The adverse effects of both treatments were also collected.

NCT ID: NCT00621751 Completed - Clinical trials for Traumatic Brain Injury

Carbamazepine for the Treatment of Chronic Post-Traumatic Brain Injury Irritability and Aggression

Start date: February 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if carbamazepine reduces irritability and aggression among individuals with traumatic brain injury

NCT ID: NCT00619463 Completed - Clinical trials for Traumatic Brain Injury

Effects of Aerobic Exercise on Cognition, Mood and Fatigue Following TBI

Start date: August 2007
Phase: N/A
Study type: Interventional

The purpose of the study is to determine the efficacy of aerobic exercise for improving cognition, mood, and fatigue after Traumatic Brain Injury (TBI) as well as examine the role of Brain Derived Neurotropic Factor (BDNF) and peripheral Vascular Endothelial Growth Factor (VEGF) as mediators of response to exercise.

NCT ID: NCT00618436 Completed - Clinical trials for Traumatic Brain Injury

Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention

Keppra
Start date: August 2007
Phase: Phase 4
Study type: Interventional

To show that the use of intravenous levetiracetam(LEV;Keppra)for seizure prevention in patients in the Neuroscience Intensive Care Unit will result in fewer side effects compared to the current standard of care anticonvulsant and will be at least as effective as the current standard of care in preventing clinical and sub-clinical seizure activity.